FDA Brief

Warning letters Drugs

FDA warning letter to

Sck Zeta Dis Ticaret, Pazarlama Ltd.

High riskIssued Jul 15, 2021Posted Jul 27, 2021Center for Drug Evaluation and Research

FDA says Turkish maker Sck Zeta's NEUTREVO hand sanitizer contained methanol instead of labeled ethanol and was refused at US border.

What happened

FDA attempted to import NEUTREVO Instant Hand Sanitizer; it was detained and refused admission at the US border. FDA laboratory testing of a border-detained batch found the product was labeled to contain 70% ethanol but contained on average 63% ethanol and 6% methanol. The product was declared as manufactured at Sck Zeta's Istanbul facility.

What FDA found

  1. The hand sanitizer was adulterated because methanol was substituted in whole or in part for the labeled active ingredient ethanol.

    FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)
  2. The methanol substitution showed that quality assurance at the facility was not working under CGMP requirements.

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)
  3. The product is an unapproved new drug because it is not generally recognized as safe and effective and has no FDA-approved application.

    FD&C Act section 505(a), 21 U.S.C. 355(a)
  4. The product is misbranded because it is dangerous to health when used as labeled due to methanol.

    FD&C Act section 502(j), 21 U.S.C. 352(j)
  5. The label is false or misleading because it says 70% alcohol but testing found less ethanol and undeclared methanol.

    FD&C Act section 502(a), 21 U.S.C. 352(a)
  6. The label does not list methanol and does not clearly distinguish active from inactive ingredients or give required ingredient quantities.

    FD&C Act section 502(e)(1)(A), 21 U.S.C. 352(e)(1)(A); 21 CFR 201.66(c)(2), (8)

What FDA wants

FDA tells the company to respond in writing within 15 working days with a detailed investigation into the methanol substitution, a list of all raw materials and suppliers, a list and reconciliation of hand sanitizer batches shipped to the US, and complete batch records. FDA also recommends a qualified CGMP consultant if the firm intends to resume making drugs for the US market.

Who should pay attention

  • brands and importers sourcing hand sanitizer from this Turkish manufacturer
  • distributors and retailers of imported OTC hand sanitizers
  • consumers and healthcare buyers relying on labeled ethanol content

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk